Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total		Class A Common Stock	Common stock Class A Common Stock	Common stock Class B Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Noncontrolling Interests
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 824,725			$ 0	$ 0	$ 1,497,373	$ (725,648)	$ (705)	$ 53,705
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2023				94,655,000	56,489,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)				1,145,000	(1,145,000)
Issuance of common stock related to vested exercised stock options (in shares)					1,120,000
Issuance of common stock related to vested exercised stock options	7,613					7,613
Repurchases, net of early exercised stock options					(11,000)
Issuance of common stock related to RSUs vested (in shares)				359,000
Charitable donation of common stock (in shares)			80,742	81,000
Charitable donation of common stock	2,675		$ 2,700			2,675
Vesting of early exercised stock options	517					517
Stock-based compensation expense	32,330					34,804			(2,474)
Change in noncontrolling interest ownership						(379)			379
Other comprehensive income (loss)	640							1,708	(1,068)
Net loss	(52,899)						(52,469)		(430)
Stockholders' Equity, ending balance (in shares) at Apr. 30, 2023				96,240,000	56,453,000
Stockholders' Equity, ending balance at Apr. 30, 2023	815,601			$ 0	$ 0	1,542,603	(778,117)	1,003	50,112
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	815,601			0	0	1,542,603	(778,117)	1,003	50,112
Stockholders' Equity, beginning balance	$ 617,934	[1]		$ 0	$ 0	1,718,661	(1,149,822)	2,335	46,760
Stockholders' Equity, beginning balance (in shares) at Jan. 31, 2024				114,670,000	42,887,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of stock (in shares)				17,236,000	(17,236,000)
Issuance of common stock related to vested exercised stock options (in shares)	561,000				561,000
Issuance of common stock related to vested exercised stock options	$ 5,093					5,093
Issuance of common stock related to RSUs vested (in shares)				711,000
Charitable donation of common stock (in shares)			53,226	53,000
Charitable donation of common stock	2,957		$ 3,000			2,957
Vesting of early exercised stock options	98					98
Stock-based compensation expense	42,252					42,548			(296)
Change in noncontrolling interest ownership						(410)			410
Other comprehensive income (loss)	911							1,025	(114)
Net loss	(54,887)						(54,644)		(243)
Stockholders' Equity, ending balance (in shares) at Apr. 30, 2024				132,670,000	26,212,000
Stockholders' Equity, ending balance at Apr. 30, 2024	614,358	[1]		$ 0	$ 0	1,768,947	(1,204,466)	3,360	46,517
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stockholders' Equity, beginning balance	$ 614,358	[1]		$ 0	$ 0	$ 1,768,947	$ (1,204,466)	$ 3,360	$ 46,517

[1] (1) As of April 30, 2024 and January 31, 2024, the condensed consolidated balance sheet includes assets of the consolidated variable interest entity, GitLab Information Technology (Hubei) Co., LTD (“JiHu”), of $46.7 million and $47.6 million, respectively, and liabilities of $6.1 million and $6.1 million, respectively. The assets of JiHu can be used only to settle obligations of JiHu and creditors of JiHu do not have recourse against the general credit of the Company. Refer to “Note 11. Joint Venture and Equity Method Investment” for further discussion.